Skip to main content
Top
Published in: Inflammation 6/2017

01-12-2017 | ORIGINAL ARTICLE

Schisandrin B Ameliorates Myocardial Ischemia/Reperfusion Injury Through Attenuation of Endoplasmic Reticulum Stress-Induced Apoptosis

Authors: Wei Zhang, Zhiqing Sun, Fanhua Meng

Published in: Inflammation | Issue 6/2017

Login to get access

Abstract

Schisandrin B (Sch B), an active composition isolated from the fruit of Schisandra chinensis, has been proved to possess antiinflammatory, antioxidant and anti-endoplasmic reticulum (ER) stress effects in many rodent tissues. However, the exact mechanism of cardioprotective effect of Sch B still needs more study. Here, we detected the effects of Sch B on myocardial ischemia/reperfusion (I/R) injury rats. I/R injury model in this study was established by left anterior descending coronary artery ligation for 40 min followed by 1 h of reperfusion. Male healthy rats were randomly divided into five groups: the sham, I/R, Sch B (20 mg/kg) + I/R, and Sch B (40 mg/kg) + I/R, Sch B (80 mg/kg) + I/R, with 10 rats in each group. We showed that Sch B treatment significantly protected against myocardial I/R injury, as demonstrated by the decrease in the percentage of infarct formation assessed by 2,3,5-triphenyl tetrazolium chloride (TTC) staining in representative heart tissue slices, comparing with the I/R control group. The levels of creatine kinase (CK), lactate dehydrogenase (LDH), malondialdehyde (MDA), and total superoxide dismutase (T-SOD) were tested. The ER stress-related proteins such as C/EBP homologous protein (CHOP), activating transcription factor 6 (ATF6), and (PKR)-like ER kinase (PERK) were further measured by western blot, and their messenger RNA levels were measured by real-time PCR. The apoptosis of heart tissue cells was also tested through the expressions of caspase-9, caspase-3, Bcl-2, and Bax proteins. Collectively, these results revealed that Sch B exerts protection role on myocardial I/R injury through decreasing oxidative reaction, suppressing ATF6 and PERK pathway, and attenuating ER stress-induced apoptosis.
Literature
1.
go back to reference Forouzanfar, M.H., A.E. Moran, A.D. Flaxman, G. Roth, G.A. Mensah, M. Ezzati, M. Naghavi, and C.J. Murray. 2012. Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010. Global Heart 7: 331–342.CrossRefPubMedPubMedCentral Forouzanfar, M.H., A.E. Moran, A.D. Flaxman, G. Roth, G.A. Mensah, M. Ezzati, M. Naghavi, and C.J. Murray. 2012. Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010. Global Heart 7: 331–342.CrossRefPubMedPubMedCentral
2.
go back to reference Ibanez, B., G. Heusch, M. Ovize, and F. Van, de Werf. 2015. Evolving therapies for myocardial ischemia/reperfusion injury. Journal of the American College of Cardiology 65: 1454–1471.CrossRefPubMed Ibanez, B., G. Heusch, M. Ovize, and F. Van, de Werf. 2015. Evolving therapies for myocardial ischemia/reperfusion injury. Journal of the American College of Cardiology 65: 1454–1471.CrossRefPubMed
3.
go back to reference Chi, H.J., Chen, M.L., Yang, X.C., Lin, X.M., Sun, H., Zhao, W.S., Qi, D., Cai, J., and Dong, J.L. 2016. Progress in therapies for myocardial ischemia reperfusion injury. Current drug targets 17. Chi, H.J., Chen, M.L., Yang, X.C., Lin, X.M., Sun, H., Zhao, W.S., Qi, D., Cai, J., and Dong, J.L. 2016. Progress in therapies for myocardial ischemia reperfusion injury. Current drug targets 17.
4.
go back to reference Yang, Q., G.W. He, M.J. Underwood, and C.M. Yu. 2016. Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection. American Journal of Translational Research 8: 765–777.PubMedPubMedCentral Yang, Q., G.W. He, M.J. Underwood, and C.M. Yu. 2016. Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection. American Journal of Translational Research 8: 765–777.PubMedPubMedCentral
6.
go back to reference Moens, A.L., M.J. Claeys, J.P. Timmermans, and C.J. Vrints. 2005. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. International Journal of Cardiology 100: 179–190.CrossRefPubMed Moens, A.L., M.J. Claeys, J.P. Timmermans, and C.J. Vrints. 2005. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. International Journal of Cardiology 100: 179–190.CrossRefPubMed
7.
go back to reference Lu, S.F., Y. Huang, N. Wang, W.X. Shen, S.P. Fu, Q. Li, M.L. Yu, W.X. Liu, X. Chen, X.Y. Jing, and B.M. Zhu. 2016. Cardioprotective effect of electroacupuncture pretreatment on myocardial ischemia/reperfusion injury via antiapoptotic signaling. Evidence-based complementary and alternative medicine : eCAM 2016: 4609784. Lu, S.F., Y. Huang, N. Wang, W.X. Shen, S.P. Fu, Q. Li, M.L. Yu, W.X. Liu, X. Chen, X.Y. Jing, and B.M. Zhu. 2016. Cardioprotective effect of electroacupuncture pretreatment on myocardial ischemia/reperfusion injury via antiapoptotic signaling. Evidence-based complementary and alternative medicine : eCAM 2016: 4609784.
8.
go back to reference Xu, C., B. Bailly-Maitre, and J.C. Reed. 2005. Endoplasmic reticulum stress: cell life and death decisions. The Journal of Clinical Investigation 115: 2656–2664.CrossRefPubMedPubMedCentral Xu, C., B. Bailly-Maitre, and J.C. Reed. 2005. Endoplasmic reticulum stress: cell life and death decisions. The Journal of Clinical Investigation 115: 2656–2664.CrossRefPubMedPubMedCentral
9.
go back to reference Liu, M.Q., Z. Chen, and L.X. Chen. 2016. Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases. Acta Pharmacologica Sinica 37: 425–443.CrossRefPubMedPubMedCentral Liu, M.Q., Z. Chen, and L.X. Chen. 2016. Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases. Acta Pharmacologica Sinica 37: 425–443.CrossRefPubMedPubMedCentral
10.
go back to reference Ron, D., and P. Walter. 2007. Signal integration in the endoplasmic reticulum unfolded protein response. Nature Reviews Molecular Cell Biology 8: 519–529.CrossRefPubMed Ron, D., and P. Walter. 2007. Signal integration in the endoplasmic reticulum unfolded protein response. Nature Reviews Molecular Cell Biology 8: 519–529.CrossRefPubMed
11.
go back to reference Thuerauf, D.J., M. Marcinko, N. Gude, M. Rubio, M.A. Sussman, and C.C. Glembotski. 2006. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circulation Research 99: 275–282.CrossRefPubMed Thuerauf, D.J., M. Marcinko, N. Gude, M. Rubio, M.A. Sussman, and C.C. Glembotski. 2006. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circulation Research 99: 275–282.CrossRefPubMed
12.
go back to reference Walter, P., and D. Ron. 2011. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334: 1081–1086.CrossRefPubMed Walter, P., and D. Ron. 2011. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334: 1081–1086.CrossRefPubMed
13.
14.
go back to reference Shen, X., K. Zhang, and R.J. Kaufman. 2004. The unfolded protein response—a stress signaling pathway of the endoplasmic reticulum. Journal of Chemical Neuroanatomy 28: 79–92.CrossRefPubMed Shen, X., K. Zhang, and R.J. Kaufman. 2004. The unfolded protein response—a stress signaling pathway of the endoplasmic reticulum. Journal of Chemical Neuroanatomy 28: 79–92.CrossRefPubMed
15.
go back to reference Panossian, A., and G. Wikman. 2008. Pharmacology of Schisandra Chinensis bail.: an overview of Russian research and uses in medicine. Journal of Ethnopharmacology 118: 183–212.CrossRefPubMed Panossian, A., and G. Wikman. 2008. Pharmacology of Schisandra Chinensis bail.: an overview of Russian research and uses in medicine. Journal of Ethnopharmacology 118: 183–212.CrossRefPubMed
16.
go back to reference Ip, S.P., M.K.T. Poon, S.S. Wu, C.T. Che, K.H. Ng, Y.C. Kong, and K.M. Ko. 1995. Effect of Schisandrin-B on hepatic glutathione antioxidant system in mice—protection against carbon-tetrachloride toxicity. Planta Medica 61: 398–401.CrossRefPubMed Ip, S.P., M.K.T. Poon, S.S. Wu, C.T. Che, K.H. Ng, Y.C. Kong, and K.M. Ko. 1995. Effect of Schisandrin-B on hepatic glutathione antioxidant system in mice—protection against carbon-tetrachloride toxicity. Planta Medica 61: 398–401.CrossRefPubMed
17.
go back to reference Checker, R., R.S. Patwardhan, D. Sharma, J. Menon, M. Thoh, H.N. Bhilwade, T. Konishi, and S.K. Sandur. 2012. Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-kappaB. Free Radical Biology & Medicine 53: 1421–1430.CrossRef Checker, R., R.S. Patwardhan, D. Sharma, J. Menon, M. Thoh, H.N. Bhilwade, T. Konishi, and S.K. Sandur. 2012. Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-kappaB. Free Radical Biology & Medicine 53: 1421–1430.CrossRef
18.
go back to reference Xu, Y., Liu, Z., Sun, J., Pan, Q.R., Sun, F.F., Yan, Z.Y., and Hu, X. 2011. Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo. Plos One 6. Xu, Y., Liu, Z., Sun, J., Pan, Q.R., Sun, F.F., Yan, Z.Y., and Hu, X. 2011. Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo. Plos One 6.
19.
go back to reference Ko, K.M. 2004. Schisandrin B and other dibenzocyclooctadiene lignans. In: Herbal Medicines: Molecular Basis in Health & Diseases Management. Marcel Dekker New York Basel Hong Kong. 289–314. Ko, K.M. 2004. Schisandrin B and other dibenzocyclooctadiene lignans. In: Herbal Medicines: Molecular Basis in Health & Diseases Management. Marcel Dekker New York Basel Hong Kong. 289–314.
20.
go back to reference Yu, D., M. Li, Y. Tian, J. Liu, and J. Shang. 2015. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury. Life Sciences 122: 15–25.CrossRefPubMed Yu, D., M. Li, Y. Tian, J. Liu, and J. Shang. 2015. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury. Life Sciences 122: 15–25.CrossRefPubMed
21.
go back to reference Duehrkop, C., and R. Rieben. 2014. Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition. Biochemical Pharmacology 88: 12–22.CrossRefPubMed Duehrkop, C., and R. Rieben. 2014. Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition. Biochemical Pharmacology 88: 12–22.CrossRefPubMed
22.
go back to reference Yim, T.K., and K.M. Ko. 1999. Schisandrin B protects against myocardial ischemia-reperfusion injury by enhancing myocardial glutathione antioxidant status. Molecular and Cellular Biochemistry 196: 151–156.CrossRefPubMed Yim, T.K., and K.M. Ko. 1999. Schisandrin B protects against myocardial ischemia-reperfusion injury by enhancing myocardial glutathione antioxidant status. Molecular and Cellular Biochemistry 196: 151–156.CrossRefPubMed
23.
go back to reference Chiu, P.Y., and K.M. Ko. 2003. Time-dependent enhancement in mitochondrial glutathione status and ATP generation capacity by schisandrin B treatment decreases the susceptibility of rat hearts to ischemia-reperfusion injury. BioFactors 19: 43–51.CrossRefPubMed Chiu, P.Y., and K.M. Ko. 2003. Time-dependent enhancement in mitochondrial glutathione status and ATP generation capacity by schisandrin B treatment decreases the susceptibility of rat hearts to ischemia-reperfusion injury. BioFactors 19: 43–51.CrossRefPubMed
24.
go back to reference Ko, K.M., and H.Y. Yiu. 2001. Schisandrin B modulates the ischemia-reperfusion induced changes in non-enzymatic antioxidant levels in isolated-perfused rat hearts. Molecular and Cellular Biochemistry 220: 141–147.CrossRefPubMed Ko, K.M., and H.Y. Yiu. 2001. Schisandrin B modulates the ischemia-reperfusion induced changes in non-enzymatic antioxidant levels in isolated-perfused rat hearts. Molecular and Cellular Biochemistry 220: 141–147.CrossRefPubMed
25.
go back to reference Chiu, P.Y., H.Y. Leung, A.H. Siu, M.K. Poon, and K.M. Ko. 2007. Schisandrin B decreases the sensitivity of mitochondria to calcium ion-induced permeability transition and protects against ischemia-reperfusion injury in rat hearts. Acta Pharmacologica Sinica 28: 1559–1565.CrossRefPubMed Chiu, P.Y., H.Y. Leung, A.H. Siu, M.K. Poon, and K.M. Ko. 2007. Schisandrin B decreases the sensitivity of mitochondria to calcium ion-induced permeability transition and protects against ischemia-reperfusion injury in rat hearts. Acta Pharmacologica Sinica 28: 1559–1565.CrossRefPubMed
26.
go back to reference Chiu, P.Y., and K.M. Ko. 2004. Schisandrin B protects myocardial ischemia-reperfusion injury partly by inducing Hsp25 and Hsp70 expression in rats. Molecular and Cellular Biochemistry 266: 139–144.CrossRefPubMed Chiu, P.Y., and K.M. Ko. 2004. Schisandrin B protects myocardial ischemia-reperfusion injury partly by inducing Hsp25 and Hsp70 expression in rats. Molecular and Cellular Biochemistry 266: 139–144.CrossRefPubMed
27.
go back to reference Qi, X., A. Vallentin, E. Churchill, and D. Mochly-Rosen. 2007. deltaPKC participates in the endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart. Journal of Molecular and Cellular Cardiology 43: 420–428.CrossRefPubMedPubMedCentral Qi, X., A. Vallentin, E. Churchill, and D. Mochly-Rosen. 2007. deltaPKC participates in the endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart. Journal of Molecular and Cellular Cardiology 43: 420–428.CrossRefPubMedPubMedCentral
28.
go back to reference Jian, L., Y. Lu, S. Lu, and C. Lu. 2016. Chemical chaperone 4-Phenylbutyric acid reduces cardiac ischemia/reperfusion injury by alleviating endoplasmic reticulum stress and oxidative stress. Medical Science Monitor 22: 5218–5227.CrossRefPubMedPubMedCentral Jian, L., Y. Lu, S. Lu, and C. Lu. 2016. Chemical chaperone 4-Phenylbutyric acid reduces cardiac ischemia/reperfusion injury by alleviating endoplasmic reticulum stress and oxidative stress. Medical Science Monitor 22: 5218–5227.CrossRefPubMedPubMedCentral
29.
go back to reference Chen, C.M., C.T. Wu, C.K. Chiang, B.W. Liao, and S.H. Liu. 2012. C/EBP homologous protein (CHOP) deficiency aggravates hippocampal cell apoptosis and impairs memory performance. PloS One 7: e40801.CrossRefPubMedPubMedCentral Chen, C.M., C.T. Wu, C.K. Chiang, B.W. Liao, and S.H. Liu. 2012. C/EBP homologous protein (CHOP) deficiency aggravates hippocampal cell apoptosis and impairs memory performance. PloS One 7: e40801.CrossRefPubMedPubMedCentral
Metadata
Title
Schisandrin B Ameliorates Myocardial Ischemia/Reperfusion Injury Through Attenuation of Endoplasmic Reticulum Stress-Induced Apoptosis
Authors
Wei Zhang
Zhiqing Sun
Fanhua Meng
Publication date
01-12-2017
Publisher
Springer US
Published in
Inflammation / Issue 6/2017
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0631-4

Other articles of this Issue 6/2017

Inflammation 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.